Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tocilizumab in combination with methotrexate for active rheumatoid arthritis in patients who had an inadequate response to non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra RoActemra (tocilizumab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-06-06